Design Therapeutics, Inc. (DSGN)
13.16
+0.04
(+0.30%)
USD |
NASDAQ |
Apr 20, 16:00
13.29
+0.13
(+0.99%)
Pre-Market: 20:00
Design Therapeutics Total Liabilities (Quarterly) : 14.25M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 188.85M |
| vTv Therapeutics, Inc. | 25.46M |
| Tactile Systems Technology, Inc. | 60.26M |
| Immuneering Corp. | 13.50M |
| X4 Pharmaceuticals, Inc. | 104.17M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 226.75M |
| Shareholders Equity (Quarterly) | 212.50M |
| Debt to Equity Ratio | 0.0072 |
| Current Ratio | 17.14 |
| Net Debt Paydown Yield | 0.03% |